Anti-Amyloid Beta Antibody (Aducanumab)
Catalog No.
F1525
Anti-Amyloid Beta Antibody (Aducanumab)
Featured Products
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid beta (Aβ). Aducanumab exhibits brain penetration and can be used in Alzheimer's disease (AD) research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.2 kDa
Dry ice
1384260-65-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Aduhelm, BIIB037, BART
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05067
Human, Mouse, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized N His HSA human Amyloid beta(APP) at 2 ug/mL can bind Anti-Amyloid Beta Antibody (Aducanumab)
Amyloid Beta
Please avoid freeze-thaw cycles.